lilotomab

Ligand id: 9950

Name: lilotomab

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
10071 lilotomab
Synonyms
Betalutin® | HH1 | tetulomab
Comments
Lilotomab is an investigational murine anti-CD37 monoclonal antibody [1]. A radioimmunoconjugate version that can be loaded with the beta radiation-emitting isotope lutetium-177 (known as 177Lu-lilotomab satetraxetan, and as the trade name Betalutin) is being evaluated as a novel radioimmunotherapeutic for the treatment of non-Hodgkin lymphoma [2]. Satetraxetan is the name of the radionuclide chelator, and this is a DOTA derivative known as (p-SCN-Bn)-DOTA (PubChem CID 10123265).
Database Links
Specialist databases
IMGT/mAb-DB 540, 541
Other databases
GtoPdb PubChem SID 374883837
Search PubMed clinical trials lilotomab
Search PubMed titles lilotomab
Search PubMed titles/abstracts lilotomab